OpenAI Acquires Orchestra Bio in Life Sciences Expansion
OpenAI acquired Orchestra Bio, a platform that helps biopharma teams use AI agents to coordinate drug development. Orchestra’s team will coordinate with OpenAI’s AI models, including Rosalind.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.